MedPath

Effect of Bupivacaine Liposome Anterior Serratus Deep Block on Chronic Pain After Breast Cancer Surgery: a Randomized Controlled Study

Not Applicable
Not yet recruiting
Conditions
Breast Cancer Patients With Chronic Pain After Surgery
Interventions
Drug: Anterior serratus block group
Registration Number
NCT06427044
Lead Sponsor
Lu Hua
Brief Summary

This study aims to investigate the effect and influence of liposome bupivacaine anterior serrat plane block on postoperative chronic pain in breast cancer patients, evaluate the therapeutic effect of liposome bupivacaine in postoperative chronic pain, and provide a new method for patients with postoperative chronic pain.

Detailed Description

Not available

Recruitment & Eligibility

Status
NOT_YET_RECRUITING
Sex
Male
Target Recruitment
143
Inclusion Criteria
  • Adult patients (aged ≥18 years) who are scheduled to undergo unilateral modified radical breast cancer surgery
Exclusion Criteria
    1. Patients with coagulation dysfunction 2. There are infected patients at the puncture site 3. For patients allergic to any trial drug 4. Patients who take painkillers within 48 hours before surgery 5. Severe cardiopulmonary insufficiency, such as EF< 40%, FEVC < 50% expected; Uncontrolled hypertension; 6. Refuse to perform nerve block puncture 7. Mental disorders, epilepsy history; 8. Unable to give informed consent or are participating in other clinical trials.

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
Anterior serratus block groupAnterior serratus block groupBupivacaine lipid 20mL (20mL 266mg bupivacaine liposomes) was ultrasound-guided for a single anterior serranus plane block
Primary Outcome Measures
NameTimeMethod
Incidence of chronic pain 3 months after surgeryThree months after surgery

Pain levels were measured three months after surgery

Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology

🇨🇳

Wuhan, Hubei, China

Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology
🇨🇳Wuhan, Hubei, China
LU HUA, 1
Contact
+8618971287754
hualuqiang@163.com

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.